| 标题 |
multi-center, Double-blind Randomized controlled trials of Chinese medicine to treatment myasthenia gravis patients
中药治疗重症肌无力的多中心双盲随机对照试验
|
| 网址 |
求助人暂未提供
|
| DOI |
暂未提供,该求助的时间将会延长,查看原因?
|
| 其它 | INTERVENTION: treatment group:Western medicine and Chinese medicines granules;control group:Western medicine and Chinese medicines granules placebo; CONDITION: G70.001 Myasthenia gravis PRIMARY OUTCOME: myasthenia gravis absolute score; SECONDARY OUTCOME: Myasthenic crisis incidence;Chinese Quality of Life Scale;myasthenia gravis quality of life scale;SF‐36 scale; INCLUSION CRITERIA: The patients with myasthenia gravis(II‐B, III, IV type), those who aged between 10‐70 years, and those who were diagnosed as the spleen and stomach Qi or spleen and kidney deficiency according to the traditional Chinese Medicine. |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)